Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase Ib Adaptive Study Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04164069
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:01.336116+00:00
Published At
2024-12-27T00:00:00+00:00
Record Updated At
2024-12-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced Colorectal Carcinoma", "Metastatic Colorectal Carcinoma", "Stage IV Colorectal Cancer AJCC v8", "Stage IVA Colorectal Cancer AJCC v8", "Stage IVB Colorectal Cancer AJCC v8", "Stage IVC Colorectal Cancer AJCC v8", "Stage II Colon Cancer", "Stage II Rectal Cancer", "Stage III Colon Cancer", "Stage III Rectal Cancer", "Esophageal Cancer", "Pancreatic Cancer", "Bile Duct Cancer", "Gastric Cancer", "Gall Bladder Cancer", "Small Bowel Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-27"
protocolSection.identificationModule.nctId
"NCT04164069"
protocolSection.identificationModule.officialTitle
"A Phase Ib Adaptive Study Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Colorectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVC Colorectal Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Colon Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Rectal Cancer (protocolSection.conditionsModule.conditions)
  • Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Pancreatic Cancer (protocolSection.conditionsModule.conditions)
  • Bile Duct Cancer (protocolSection.conditionsModule.conditions)
  • Gastric Cancer (protocolSection.conditionsModule.conditions)
  • Gall Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Small Bowel Adenocarcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.